Atlas Trials

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.

Clinical trial NCT05984537 · RECRUITING

Trial details

NCT number
NCT05984537
Sponsor
Peking University First Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Microvascular Dysfunction
Start date
2023-07-01
Primary completion
2025-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.